click below
click below
Normal Size Small Size show me how
NRSG Pharm CH 13
Adrenergic / Antiadrenergic
Question | Answer |
---|---|
agents involved in neurotransmission | catecholamines |
natural catecholamines / synth catecholamines | N: NE (main, released by most postganglionic nerves), Epi, dopamine S: isoproterenol, dobutamine |
Adrenergic where? | Adrenergic receptors @ end of postganglionic symp neurons |
A1 adrenergic receptors, location/response | In all symp target organs except heart. Vasoconstriction, pupil dilation |
B2 adrenergic receptors, location/response | All symp target organs except heart, INHIBIT smooth muscle |
NE @ A1 | All symp except heart, vasoconstriction, dilation of pupils |
NE @ A2 | Presynaptic adrenergic nerve terminals, inhibit release of NE |
NE @ B1 | Heart and kidneys - Inc HR, force of contraction (CO), renin release (BP inc) |
NE @ B2 | All symp except heart, inhibit smooth muscle |
NE @ B3 | Adipose - lipolysis, urinary bladder - relaxation of detrusor muscle |
5 mechs by which Rx affect synaptic tx | 1 Affect synthesis of neruotx in terminal 2 prevent storage of neruotx in vesicles in presynaptic 3 influence release 4 prevent normal destruction/reuptake 5 bind @ receptor site on postsynaptic target tissue |
Prototype: Phenylephrine (Neo-Synephrine) classes, mech | T: nasal decongestant; antihypotensive P: Adrenergic drug (sympathomimetic)) Mech: stimulates symp directly/indirectly - many same responses as anticholinergic |
Sympathomimetics @ receptors, primary uses: | A1 nasal congestion, hypotension, dilation of pupils -> eye exam A2 hypertension B1 Cardiac arrest, heart failure, shock B2 asthma, premature-labor contractions |
Side/Adverse sympathomimetics | tachy, hypertension, dysrhythmias, CNS excitation and seizues, dry mouth, N/V, anorexia |
phenylephrine (Neo-Synephrine) actions/uses | selective alpha-adrenergic agonist, reduces nasal congestion by vasoconstriction in nasal mucosa |
phenylephrine (neo-Synephrine) side/adverse | uncommon, irritation, rebound congestion if used for prolonged periods |
Adrenergic considerations: | Vitals, urinary, cardiac breathing patterns responsiveness to light (pupil dilation) Rhinorrhea and epistaxis |
Adrenergic-blocking agents primary use / other therapeutic applications | Primary: beta blockers for hypertension Other: Angina pectoris, migraines, heart failure |
Prototype: Prazosin (MiniPress) classes, mech | P: Adrenergic-blocking T: Hypertension drug M: selective A1 adrenergic antagonist - competes with NE @ receptor sites on vascular smooth muscles in arterioles and veins - blocks vasoconstriction of NE @ A1 |
Prazosin (MiniPress) primary uses: | Hypertension, dysrhythmias, angina, heart failure, benign prostatic hypertrophy, narrow-angle glaucoma |
Prazosin (MiniPress) adverse: | dizziness, drowsiness, headache, dec energy/strength, palpitations, dry mouth |
Adrenergic-blocking agents main side/adverse: | Orthostatic hypotension! - rare, can cause LOC 30 min after first dose dizziness, drowsiness, light-headed, reflex tachy |
adrenergic-blocking considerations | first dose should be low and given at bedtime |